Apex Medical Acquires Further Interest in UK Based Westmeria Healthcare
Taipei, Taiwan – 28th August 2015. Apex Medical Corp. (APEX), (TWSE listed Company (ref code 4106)) announced today that it has completed its largest acquisition to date in acquiring Westmeria Healthcare Limited (Westmeria), a leading UK provider of Pressure Area Care (PAC) therapy effective Aug 31st 2015. The transaction shows Apex Medical Corp. ambition and has made a great progress in the global wound management space.
“The acquisition of Westmeria will provide APEX with a solid platform in the wound management spaces, while increasing our service capabilities and spurring our growing presence in Europe,” said Daniel Lee, General Manager of Apex Medical Corp. “We will continue to grow the Westmeria services and channels along with APEX’s extensive portfolio of medical equipment. We will import a series of new wound management products & support surface. In the foreseeable future our aim is to become the go-to source for all of our customers’ medical equipment and service needs across the UK. Meanwhile, APEX continues to invest in manpower and marketing support to provide world-class products and enhanced service coverage across the UK.”
Jon Jauregui, Director General of Apex Medical Europe, noted “As part of our global expansion program, APEX will continue to extend and develop its international operations with a particular focus on the European Medical Market. David Francis, Founder of Westmeria, added ‘I wish APEX & everyone at Westmeria Healthcare well for the future and would like to add my thanks to my fellow directors for the past ten years, with a special mention to Phil Isherwood, Chairman, who is greatly missed by us all’.
Westmeria Healthcare Ltd. will continue to operate under their current management structure, led by Managing Director Nicola Rodker and who will now join the Apex Medical Corp. in Europe.
In recent years, APEX has rapidly established regional subsidiaries and a consolidated service network in Europe, America, China, and India to provide direct service aligned to regional requirements. APEX continues towards significant and sustained growth all over the world by providing healthcare solutions to both improve patients’ quality of life and reduce total healthcare cost.
Apex Medical is a leading manufacturer of its own brand of Wound Management and Respiratory Therapy products and distributes through an established network of international subsidiaries and partners in Europe, the United States, Asia and other international markets. APEX specializes in product development, engineering and marketing products with a dedicated and innovative team of industry professionals. APEX aims to be a global leader in the provision of high quality healthcare products, delivering tested, trialed and clinically evaluated devices while ensuring that its own technology and intellectual property meet the demands of the Wound Management and Respiratory Therapy market.